Telehealth for Diabetes Care During Coronavirus Disease 2019 Pandemic

Abstract

Get full access to this article

View all access options for this article.

References

Katulanda

Dissanayake

Ranathunga

, et al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia. 2020;63(8):1440-1452.

Bornstein

Rubino

Khunti

, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-550.

Wake

Gibb

Kar

, et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: remodelling diabetes services and emerging innovation. Eur J Endocrinol. 2020;183(2):G67-G77.

Schofield

Leelarathna

Thabit

. COVID-19: impact of and on diabetes. Diabetes Ther. 2020;11(7):1429-1435.

Tchero

Kangambega

Briatte

Brunet-Houdard

Retali

Rusch

. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health. 2019;25(7):569-583.

Danne

Limbert

Puig Domingo

, et al. Telemonitoring, telemedicine and time in range during the pandemic: paradigm change for diabetes risk management in the post-COVID future. Diabetes Ther. 2021;12(9):2289-2310.

Predieri

Leo

Candia

, et al. Glycemic control improvement in Italian children and adolescents with type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic. Front Endocrinol (Lausanne). 2020;11:595735.